)
Edge15 May 2026
TOMRA: Closing the Loop
The story of TOMRA: from reverse vending machine pioneer to global technology for deposit systems, recycling, and resource optimization.
AB SCIENCE
AB SCIENCE (AB) investor relations material
AB SCIENCE H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary13 May, 2026
Executive summary
Operating loss as of 31 December 2025 was €3.8 million, down 38% year-over-year, excluding non-recurring items.
Cash position at year-end was €10.2 million, with an additional €3.2 million raised in April 2026.
Focused clinical resources on Phase 3 of masitinib in ALS and Phase 1 of AB8939 in AML.
Final agreement reached on renegotiation of loan repayment terms with all financial creditors.
Financial highlights
Revenue from veterinary medicine increased 10% year-over-year to €1.17 million.
Operating expenses fell by 93% due to a non-recurring cancellation of a repayable advance and cost controls.
Net loss for 2025 was €1.56 million, an 80% reduction from 2024.
Net earnings per share improved to (€0.03) from (€0.15) year-over-year.
Outlook and guidance
Strategic focus on Phase 3 masitinib in ALS and Phase 1 AB8939 in AML, deprioritizing other indications.
Temporary suspension of European clinical trials to address regulatory and organizational requirements.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from AB SCIENCE
- AB8939 shows strong efficacy in refractory and MECOM AML, with Phase II trials and funding secured.AB
Status Update11 Jan 2026 - Masitinib advances in neurodegenerative diseases with new trials and a January 2025 update webcast.ABStatus Update9 Jan 2026
- AB8939 plus venetoclax showed 100% response in high-risk AML with no hematological toxicity.ABStatus Update16 Oct 2025
- Operating loss fell 24% but net loss rose; €6.3M raised for clinical and patent milestones.ABH1 202510 Oct 2025
- Net loss halved and cash position improved, but regulatory and tax risks remain.ABH1 202413 Jun 2025
- Operating loss halved and cash bolstered as clinical pipeline advances and IP portfolio grows.ABH2 20246 Jun 2025
Next AB SCIENCE earnings date
H1 202631 Aug, 2026
AB SCIENCE
Next AB SCIENCE earnings date
H1 202631 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage